Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

dihydrobunolol

Known as: 1-Naphthalenol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, dihydrolevobunolol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Although ocular transport and delivery have been well studied, metabolism in the eye is not well documented, even for clinically… Expand
  • table 1
Is this relevant?
1991
1991
The objective of this study was to determine which of the five or six corneal epithelial layers was rate-limiting in the corneal… Expand
Is this relevant?
1988
1988
The distribution of ketone reductase activity in the anterior segment tissues of the pigmented rabbit eye and its influence on… Expand
Is this relevant?
1987
1987
The ocular and systemic disposition of levobunolol (LBUN), an antiglaucoma agent, was studied in albino rabbits. After topical… Expand
Is this relevant?
1987
1987
ABSTRACT The ocular β-adrenoceptor antagonist activity of dihydrolevobunolol (DHLB), the major ocular and systemic metabolite of… Expand
Is this relevant?
1987
1987
The ocular beta-adrenoceptor antagonist activity of dihydrolevobunolol (DHLB), the major ocular and systemic metabolite of… Expand
Is this relevant?
1984
1984
Binding of 3H-dihydroalprenolol (3H-DHA) to beta-adrenoceptors in homogenates from rat and rabbit lung was homogeneous and of… Expand
Is this relevant?
1977
1977
The metabolism of I‐bunolol, a new f3‐blocking drug, was studied in man after single oral 3‐mg doses of W‐labeled compound… Expand
Is this relevant?
1972
1972
1. Cell-free preparations from human liver taken at autopsy were used to biosynthesize a metabolite from bunolol. The metabolite… Expand
Is this relevant?